Discover
OBIO
Orchestra BioMed Holdings, Inc.
4.30
2 x 3.14
2 x 5.42
bid
ask
-
0.02
0.35%
2 @ 04:00 PM
4.30 +0.00 (0.00%)
| Ytd | 3.61% | |
| 1y | 55.23% |
4.21
day range
4.36
2.20
52 week range
5.42
| Open | 4.29 | Prev Close | 4.32 | Low | 4.21 | High | 4.36 | Mkt Cap | 257.49M |
| Vol | 267.08K | Avg Vol | 313.35K | EPS | -0.95 | P/E | N/A | Forward P/E | -2.66 |
| Beta | 0.41 | Short Ratio | 12.51 | Inst. Own | 54.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.03 | 200-d Avg | 4.03 | 1yr Est | 15.60 |
| Income Statement | |||
| Total Revenue | 110.00K | ||
| Revenues (USD) | 110.00K | ||
| Cost of Revenue | 32.00K | ||
| Gross Profit | 78.00K | ||
| Operating Expenses | 22.15M | ||
| Research and Development Expense | 15.78M | ||
| Selling, General and Administrative Expense | 6.37M | ||
| Operating Income | -22.08M | ||
| Interest Expense | 821.00K | ||
| Net Income | -20.69M | ||
| Net Income Common Stock | -20.66M | ||
| Net Income Common Stock (USD) | -20.66M | ||
| Consolidated Income | -20.69M | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -19.87M | ||
| Earning Before Interest & Taxes (USD) | -19.87M | ||
| Preferred Dividends Income Statement Impact | -35.00K | ||
| Weighted Average Shares | 62.72M | ||
| Weighted Average Shares Diluted | 62.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.37M | ||
| Cash and Equivalents (USD) | 28.37M | ||
| Investments | 66.03M | ||
| Investments Current | 66.03M | ||
| Trade and Non-Trade Receivables | 84.00K | ||
| Current Assets | 96.21M | ||
| Property, Plant & Equipment Net | 3.19M | ||
| Total Assets | 100.66M | ||
| Debt Current | 785.00K | ||
| Total Debt | 33.64M | ||
| Current Liabilities | 13.69M | ||
| Debt Non-Current | 32.85M | ||
| Total Liabilities | 49.69M | ||
| Accumulated Retained Earnings (Deficit) | -383.27M | ||
| Accumulated Other Comprehensive Income | -40.00K | ||
| Shareholders Equity | 41.19M | ||
| Shareholders Equity (USD) | 41.19M | ||
| Assets Non-Current | 4.45M | ||
| Total Debt (USD) | 33.64M | ||
| Inventory | 277.00K | ||
| Liabilities Non-Current | 36.00M | ||
| Trade and Non-Trade Payables | 6.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 249.00K | ||
| Net Cash Flow from Financing | 5.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.32M | ||
| Capital Expenditure | -184.00K | ||
| Issuance (Purchase) of Equity Shares | 5.88M | ||
| Net Cash Flow from Investing | 10.32M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.50M | ||
| Net Cash Flow from Operations | -22.17M | ||
| Share Based Compensation | 2.85M | ||